PX1 Research provides synthetic GHRP-2 (Pralmorelin) synthesized to strict purity standards for in vitro and preclinical laboratory applications. Every lot undergoes rigorous analytical testing—including RP-HPLC and mass spectrometry—to guarantee exact sequence identity and quantitative purity for demanding research environments.
PX1 Research provides synthetic GHRP-2 (Pralmorelin) synthesized to strict purity standards for in vitro and preclinical laboratory applications. Every lot undergoes rigorous analytical testing—including RP-HPLC and mass spectrometry—to guarantee exact sequence identity and quantitative purity for demanding research environments.
When procuring a GHRP-2 research peptide for sale, laboratory researchers require high-purity compounds verified through transparent, third-party analytical testing. GHRP-2 (Pralmorelin) is a synthetic growth hormone secretagogue hexapeptide evaluated in preclinical models for GHS-R1a receptor binding and somatotroph activation assays. PX1 Research supplies USA-manufactured GHRP-2 with lot-specific HPLC and mass spectrometry verification to ensure baseline experimental reproducibility.
Obtaining validated reference materials is vital when examining growth hormone axis pathways, receptor kinetics, and downstream metabolic cascades. Investigators evaluating research peptides rely on rigorous analytical documentation to rule out synthetic impurities, residual solvents, or truncated peptide sequences that could skew cell culture measurements or animal model assays.
PX1 Research maintains a fully transparent chain of custody for all inventory. Every vial of our GHRP-2 research peptide is manufactured in GMP-compliant facilities and tested by independent ISO 17025 accredited laboratories prior to release into our distribution network.
GHRP-2 is a synthetic hexapeptide with the chemical sequence D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 and a molecular formula of C45H55N9O6, yielding a molecular mass of approximately 818.0 g/mol. As a second-generation growth hormone-releasing peptide, it functions as a potent agonist at the ghrelin/growth hormone secretagogue receptor type 1a (GHS-R1a).
Preclinical binding assays indicate that GHRP-2 binds GHS-R1a with high nanomolar affinity, triggering a conformational shift that activates the phospholipase C (PLC) signaling cascade. This activation stimulates inositol trisphosphate (IP3) production and intracellular calcium flux within anterior pituitary somatotrophs, leading to the exocytosis of endogenous growth hormone stores in vitro.
Detailed evaluations of the compound's structure-activity relationship (SAR) reveal that the inclusion of D-amino acids—specifically D-alanine, D-2-naphthylalanine, and D-phenylalanine—confers significant resistance against enzymatic degradation by serine proteases and carboxypeptidases in blood plasma models. Researchers exploring these pathways can review deeper technical data in our dedicated GHRP-2 research library hub.
In vitro and rodent research models utilize GHRP-2 across several experimental paradigms. Primary research avenues include evaluating somatotroph responsiveness, investigating ghrelin receptor crosstalk, and quantifying intracellular secondary messenger cascades.
Key areas of preclinical inquiry include:
• Somatotroph Secretion Kinetics: In vitro cell culture studies measure real-time GH exocytosis from isolated pituitary cells exposed to varying concentrations of synthetic secretagogues. • Ghrelin Axis Signaling: Animal models utilize GHRP-2 to dissect the central nervous system pathways regulating food intake, energy expenditure, and orexigenic neurocircuitry in the hypothalamus. • Cytoprotective Mechanisms: Preclinical cardiac and hepatic injury models explore potential non-endocrine signaling pathways mediated by peripheral GHS-R1a expression. • Growth Axis Synergy: Dual-agent assays investigate co-administration dynamics between ghrelin receptor agonists and growth hormone-releasing hormone (GHRH) analogs like CJC-1295 No DAC.
To explore additional mechanistic documentation on receptor agonists and secretagogue dynamics, visit our growth hormone secretagogues guide.
When designing comparative secretagogue protocols, investigators frequently compare GHRP-2 against other prominent peptides within the growth hormone secretagogue class, such as GHRP-6 and Ipamorelin. While all three compounds engage the GHS-R1a receptor, their selectivity profiles, receptor binding dynamics, and secondary endocrine effects differ notably in preclinical literature.
In cell culture assays, GHRP-2 demonstrates substantially higher somatotroph secretagogue potency than GHRP-6, requiring lower nanomolar concentrations to induce equivalent calcium ion mobilization. However, GHRP-2 exhibits modest cross-reactivity with central ghrelin pathways, stimulating orexigenic responses in rodent models, whereas Ipamorelin demonstrates extreme receptor selectivity with minimal stimulation of ACTH, cortisol, or appetite signaling.
Evaluating these nuanced differences allows researchers to select the optimal compound based on whether their protocol demands maximum somatotroph stimulation, strict receptor selectivity, or broader metabolic receptor engagement.
High-throughput screening and quantitative assays require uncompromised chemical purity. Inferior peptides containing synthesis side-products, TFA salts, or heavy metals introduce unquantifiable variables that jeopardize laboratory reproducibility.
PX1 Research establishes the industry standard for scientific procurement by adhering to seven critical quality criteria:
1. Verified Purity: Minimum 98% purity confirmed by High-Performance Liquid Chromatography (HPLC). 2. Mass Verification: Electrospray Ionization Mass Spectrometry (ESI-MS) confirming exact molecular weight (818.0 Da). 3. Endotoxin Testing: Limulus Amebocyte Lysate (LAL) assays ensuring endotoxin levels remain below 0.01 EU/μg. 4. Independent Validation: Every lot is tested by accredited ISO 17025 third-party laboratories in the United States. 5. Domestic Manufacturing: Synthesized in state-of-the-art, GMP-compliant facilities in the USA. 6. Complete Traceability: Individual lot numbers printed on every vial, linking directly to downloadable Certificates of Analysis (COA). 7. Expedited Logistics: Orders ship same-day (Monday–Friday) from our dual fulfillment centers in California and Arizona.
Principal investigators managing institutional grants or multi-phase studies can request customized pricing and bulk documentation via our wholesale portal.
To maintain peptide integrity and prevent premature enzymatic breakdown or aggregation, laboratory technicians must follow precise reconstitution procedures using sterile laboratory media.
Lyophilized GHRP-2 cake should be reconstituted using sterile Bacteriostatic Water (0.9% benzyl alcohol) or Sterile Normal Saline (0.9% NaCl), depending on assay requirements. Reconstitution with plain sterile water without antimicrobial agents is suitable strictly for immediate, single-use in vitro experiments.
Recommended handling protocol:
• Allow the sealed vial to equilibrate to ambient room temperature before inserting a syringe to prevent moisture condensation inside the vacuum-sealed container. • Clean the rubber stopper using a 70% isopropyl alcohol wipe in a laminar flow hood. • Gently direct the reconstituting solvent down the glass wall of the vial rather than shooting directly onto the freeze-dried peptide cake. • Swirl the vial with a gentle circular motion until completely dissolved. Never shake or vortex peptide solutions, as high mechanical shear stress can disrupt peptide tertiary structure and induce aggregation.
For step-by-step mathematical calculations regarding concentration per volume, reference our interactive peptide reconstitution guide.
Lyophilized GHRP-2 demonstrates excellent long-term chemical stability when stored under controlled low-temperature conditions. Unopened vials should be stored at -20°C in a desiccated environment, shielded from light exposure, where they remain stable for up to 24 months from the date of synthesis.
Once reconstituted into aqueous solution, the peptide becomes significantly more susceptible to hydrolysis and oxidation. Reconstituted liquid aliquots should be maintained at 2°C to 8°C and utilized within 30 days. For long-term liquid storage, reconstitute in single-use aliquots and store at -80°C to minimize degradation.
Repeated freeze-thaw cycles must be rigorously avoided. Freeze-thaw stress alters local pH, increases solute concentration during ice crystal formation, and dramatically increases the rate of peptide chain cleavage.
Understanding analytical documentation is vital when validating a vendor's claims regarding a GHRP-2 research peptide for sale. PX1 Research provides clear, unabridged documentation for every lot released.
A standard Certificate of Analysis (COA) includes two core analytical outputs:
Reverse-Phase HPLC (RP-HPLC): This chromatographic separation measures chemical purity by separating the target peptide from synthesis impurities, truncated sequences, and protecting group artifacts. Purity is calculated as the percentage area of the primary peak relative to total integrated peak area at a detection wavelength of 214 nm or 220 nm.
Mass Spectrometry (ESI-MS): Mass spectrometry verifies chemical identity. Electrospray ionization measures the mass-to-charge ratio (m/z) of the molecule. For GHRP-2, the spectra must display a prominent mono-charged peak ([M+H]+) at 818.0 m/z or predicted multi-charged adduct peaks corresponding exactly to the theoretical mass.
To review sample chromatograms or request specific analytical files prior to placing an order, consult our analytical research documentation hub.
Where can I find a ghrp-2 research peptide for sale with verified purity?
PX1 Research offers high-purity GHRP-2 research peptides manufactured in the USA. Every batch is independently verified by third-party ISO 17025 laboratories using RP-HPLC and ESI-MS to ensure purity levels equal to or exceeding 98%.
What is the purity level of PX1 Research GHRP-2?
PX1 Research guarantees a minimum purity of 98% for all GHRP-2 lots. Each vial is accompanied by a lot-specific Certificate of Analysis (COA) detailing the exact HPLC purity percentage and mass spectrometry verification.
Is GHRP-2 supplied by PX1 Research intended for human consumption?
No. All products sold by PX1 Research, including GHRP-2, are strictly designated for laboratory research, in vitro assays, and preclinical animal studies. They are not for human or veterinary use, therapy, or clinical administration.
What is the molecular weight and sequence of GHRP-2?
GHRP-2 (Pralmorelin) has a molecular weight of 818.0 g/mol and a chemical sequence of D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2.
How should lyophilized GHRP-2 be stored upon arrival?
Lyophilized GHRP-2 should be stored at -20°C in a dry, dark freezer upon receipt. Under these conditions, the dry powder remains stable for up to 24 months.
How long does reconstituted GHRP-2 remain stable in the laboratory?
When reconstituted with bacteriostatic water under sterile conditions, GHRP-2 solution remains stable at 2°C to 8°C (refrigerated) for up to 30 days. Aliquots stored at -80°C remain viable for longer periods, provided freeze-thaw cycles are avoided.
What diluent should be used to reconstitute GHRP-2 for in vitro studies?
For multi-dose or extended cell culture experiments, sterile Bacteriostatic Water (0.9% benzyl alcohol) is standard. For immediate, acute in vitro assays where preservatives might interfere with cell viability, sterile 0.9% NaCl saline is recommended.
Are PX1 Research peptides tested for endotoxins?
Yes. Every lot of GHRP-2 undergoes Limulus Amebocyte Lysate (LAL) testing to ensure bacterial endotoxin levels are maintained well below standard research threshold limits (<0.01 EU/μg).
How fast does PX1 Research ship GHRP-2 orders?
Orders placed before cutoff times ship the same day, Monday through Friday, from our dual warehouse facilities located in California and Arizona.
Can institutions purchase GHRP-2 in bulk for large-scale studies?
Yes. PX1 Research supports institutional procurement, university grant projects, and corporate R&D facilities with bulk volume discounts and dedicated account management through our wholesale program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.